主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
The clinical efficacy of tislelizumab combined with Nab-PP in the treatment of advanced lung squamous cell carcinoma with high PD-L1 expression
LI Meng, ZHANG Xueqin, ZHAO Chenyang, XING Yuan
World Clinical Drug . 2025, (12): 1290 .  DOI: 10.13683/j.wph. 2025.12.014